share_log

天宇股份(300702.SZ):二甲双胍恩格列净片药品获得批准

Zhejiang Tianyu Pharmaceutical (300702.SZ): Metformin and Ertugliflozin tablets have been approved.

Gelonghui Finance ·  Dec 23, 2024 18:45

On December 23, Gelonghui reported that Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary, Zhejiang Nuode Pharmaceutical Co., Ltd., recently received the drug registration certificates approved and issued by the National Medical Products Administration for Metformin Ertugliflozin Tablets (Ⅴ) and Metformin Ertugliflozin Tablets (Ⅵ). Metformin Ertugliflozin Tablets are blood glucose-lowering medications. This product, in conjunction with dietary control and exercise, is suitable for adult patients with type 2 diabetes who are receiving treatment with Ertugliflozin and Metformin hydrochloride to improve glycemic control in these patients.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment